Bahl & Gaynor’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-35,023
Closed -$2.73M 348
2021
Q1
$2.73M Buy
35,023
+644
+2% +$50.2K 0.02% 213
2020
Q4
$2.28M Sell
34,379
-73
-0.2% -$4.85K 0.01% 226
2020
Q3
$2.15M Sell
34,452
-21,750
-39% -$1.36M 0.02% 218
2020
Q2
$3.57M Buy
56,202
+223
+0.4% +$14.1K 0.03% 165
2020
Q1
$4.02M Sell
55,979
-148
-0.3% -$10.6K 0.04% 143
2019
Q4
$4.85M Buy
56,127
+2,022
+4% +$175K 0.03% 148
2019
Q3
$4.43M Buy
54,105
+4,229
+8% +$346K 0.03% 155
2019
Q2
$4.05M Buy
49,876
+4,565
+10% +$371K 0.03% 160
2019
Q1
$3.44M Buy
45,311
+12,760
+39% +$968K 0.03% 159
2018
Q4
$2.55M Buy
32,551
+12,875
+65% +$1.01M 0.03% 177
2018
Q3
$1.48M Sell
19,676
-3,071
-14% -$231K 0.02% 240
2018
Q2
$1.6M Buy
22,747
+4,556
+25% +$321K 0.02% 231
2018
Q1
$1.09M Sell
18,191
-455
-2% -$27.1K 0.01% 272
2017
Q4
$1.14M Buy
18,646
+4,265
+30% +$260K 0.01% 269
2017
Q3
$899K Buy
14,381
+2,441
+20% +$153K 0.01% 272
2017
Q2
$837K Buy
11,940
+610
+5% +$42.8K 0.01% 285
2017
Q1
$808K Buy
11,330
+250
+2% +$17.8K 0.01% 274
2016
Q4
$840K Buy
11,080
+770
+7% +$58.4K 0.01% 260
2016
Q3
$680K Buy
10,310
+505
+5% +$33.3K 0.01% 285
2016
Q2
$635K Buy
9,805
+715
+8% +$46.3K 0.01% 286
2016
Q1
$566K Buy
9,090
+10
+0.1% +$623 0.01% 297
2015
Q4
$560K Buy
9,080
+220
+2% +$13.6K 0.01% 299
2015
Q3
$539K Buy
8,860
+205
+2% +$12.5K 0.01% 305
2015
Q2
$562K Buy
8,655
+2,935
+51% +$191K 0.01% 314
2015
Q1
$364K Buy
+5,720
New +$364K ﹤0.01% 348